CLDN12

mutation — cross-omics
Cross-omicsMUTATION → RNACell-linePairwise association · TCGA cohorts

Across TCGA cell cohorts, CLDN12 mutation is significantly associated with the RNA expression of many other genes, with 3 significant associations in total. BREAST shows the largest number of these associations.

The most reproducible CLDN12-associated genes across cancer lineages are VCY1B, DEFB125, and OR2B3. Each is linked with CLDN12 in more than 1 cancer types. Because this analysis shows association rather than direction, both CLDN12-to-partner and partner-to-CLDN12 results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, VCY1B grouped by CLDN12-low versus CLDN12-high in BREAST.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (CLDN12→partner) and Y-score (partner→CLDN12) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
BREASTVCY1B →+1.590+4.421<.001.00431
BREASTDEFB125 →+0.036+5.312<.001<.00131
BREASTOR2B3 →+0.015+4.781<.001.00331
Each partner links to its Q-omics profile. Showing the 3 strongest of 3 associations by consensus.

VCY1B by CLDN12 expression — BREAST

Box plot of VCY1B in CLDN12-low vs CLDN12-high samples in BREAST.

Explore this box plot interactively →

Exploration